Facebook
Twitter
LinkedIn
ForwardPharmacogenomics in Clinical Practice: Essential Concepts – Online CME Course
Online CME Course - Available until October 31, 2022
Course Directors | |
 | Timothy B. Curry, M.D., Ph.D. |
 | Denise M. Dupras, M.D., Ph.D. |
Intended for providers wanting a general background in Pharmacogenomics, Essential Concepts covers an introduction in foundational pharmacogenomic concepts. This module is specifically curated from the more extensive Pharmacogenomics for Your Practice - Online certificate program. Mayo Clinic experts review legal implications, the process of laboratory testing, and the clinical application of pharmacogenomics in depression, HLA, cardiovascular disease, and polypharmacy.
Target Audience
This activity has been designed for pharmacists, physicians, nurse practitioners, physician assistants, nurses, students, and other members of the health care team.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Describe what to consider when implementing pharmacogenomics in clinical practice
- Apply pharmacogenomics test results to make recommendations for an individualized medication management plan
- Identify barriers and challenges of considering pharmacogenomics in patient care
Utilization of this Mayo Clinic online (enduring materials) course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be in this course.
IMPORTANT DISCLAIMER: Some content in this course is included in other CME courses (Pharmacogenomics in Clinical Practice: Oncology - Online CME Course and Pharmacogenomics in Clinical Practice: Applications in Clinical Care - Online CME Course). If you do enroll and receive credit from this course, you will not be eligible to claim it for Pharmacogenomics in Clinical Practice: Oncology - Online CME Course and Pharmacogenomics in Clinical Practice: Applications in Clinical Care - Online CME Course. If duplicate credit is accidentaly claimed, it will not be valid should any auditing occur. Pleae do not hesitate to contact us with any qeustions prior to purchasing.
Additional Information
| Attachment | Size |
|---|---|
 Additional Information | 149.79 KB |
 | Pharmacogenomics 101: An Introduction to Foundational Concepts Christopher T. Grilli, Pharm.D., R.Ph., M.B.A. | Over the past 30 years, pharmacogenomics has been making waves throughout the medical field. What does this mean for whole-patient care? Learn the basics of genomics and genetic concepts in this lecture! |
 | Pharmacogenomics: Discovery and Translation Liewei Wang, M.D., Ph.D. | You learned the basics of pharmacogenomics. But how has pharmacogenomics implemented in practice? In this lecture, learn about the research opportunities and challenges within this developing field! |
 | Variability and Pharmacokinetic Principles Wayne T. Nicholson, M.D., Pharm.D. | Is pharmacogenomics for everyone? What factors influence individual drug variability? Find out these answers and more in this lecture! |
 | PGx from a Patient Perspective: GINA & Other Important Questions Teresa M. Kruisselbrink, M.S., CGC, LCGC | Are you interested in genetic testing but are afraid of its impact on employment and health insurance? Have no fear, GINA is here! This lecture will describe the protections offered by the Genetic Information Non-Discrimination Act (GINA) and its limitations of protections. |
 | Legal Implications of Pharmacogenomics Testing Sharon C. Zehe, J.D. | With the rise of pharmacogenomics testing, providers may have concerns of the risk of malpractice with these tests. With this lecture you'll understand the elements of malpractice and apply them to PGx testing. |
 | Clinical Laboratory Testing in PGx: "The Lab" 101 Ann M. Moyer, M.D., Ph.D. | So you wanna order a pharmacogenomics test. But how can the laboratory help you? Find out how the pharmacogenomics laboratory can help your practice in this lecture! |
 | Clinical Laboratory Testing in PGx: "Reporting" Ann M. Moyer, M.D., Ph.D. | So you got the test results. But how does the lab translate raw data into test results? Learn how and more in this lecture! |
 | Pharmacogenomics of Analgesics Wayne (Nick) T. Nicholson, M.D., Pharm.D. | Due to its subjective nature, pain can be difficult to manage. We have begun to see the use of pharmacogenomics for analgesics. In this video, apply your knowledge with a case you may experience in your practice! |
 | Pharmacogenomics of Antidepressants Adrijana Kekic, Pharm.D., R.Ph. | Did you know, there are over 160 drug labels with human genomic biomarker? And there are over 100 drugs with PGx biomarkers in drug labeling? With almost 1/3 of them being psychotropic drugs, learn how to interpret the effect of genetic variants on antidepressants pharmacology! |
 | Case Review: Antidepressants, SSRIs, (Sertraline) and SNRIs Adrijana Kekic, Pharm.D., R.Ph. | So you learned about pharmacogenomics and antidepressants. But how about genetic variants related to pharmacology of SSRIs and SNRIs? How can you identify them? In this lesson, learn how to interpret genomic results in the context of medication management. |
 | Using Pharmacogenomics to Predict Drug Hypersensitivity John D. Zueli, Pharm.D., R.Ph. | Human Leukocyte Antigen (HLA) Drug Hypersensitivity. What does it mean? Why do they occur? In this lesson, learn to explain how HLA mutations lead to drug hypersensitivity and abacavir screening recommendations. |
 | HLA and Hypersensitivity Jyothsna (Jo) Giri, M.D., M.B.A. | Medication is on the major causes of adverse drug reactions - increasing exponentially with four or more medications. This video showcases genetic variations that cause medication induced ADR. Tune into this case study to learn the association between carbamazepine and hypersensitivity reactions. |
 | Pharmacogenomics in Cardiovascular Disease Naveen L. Pereira, M.D. | Join Dr. Pereira as he explains how genetic variation can effect your response on cardiovascular drug response! Have the opportunity to review the literature with examples of the genetic variation response in action! |
 | Polypharmacy and PGx: Multi-Drug, Herbal/Dietary Supplement Case Study Michael J. Schuh, Pharm.D., R.Ph. | Herbal supplements have been popular to the public, dating back to the beginning of time! But how do these herbal supplements impact pharmacogenomics? Are there herbal supplement and drug interactions? Learn more in this video! |
 | 10 Considerations for the Clinician Applying Pharmacogenomics to Practice Wayne T. Nicholson, M.D., Pharm.D. | So you want to include pharmacogenomics in your practice. Should you order a pharmacogenomics test? Should you order a single gene test or a panel? Find out with Dr. Wayne Nicholson! |
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 6.00 knowledge-based contact hours. Participants should only claim credit commensurate with the extent of their participation in the activity.
ACPE UAN Number: JA0000238-0000-21-087-H01-P
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 6.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 6.00 ACPE
- 6.00 AMA PRA Category 1 Credit™
- 6.00 ANCC
- 6.00 Attendance
Price
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.